Table 2.
Risk of CHD (MI/ CHD deaths) (HR with 95 % CIs) per minor allele of AHSG genotypes and per 1 SD difference in genetically predicted fetuin-A in CHS cohort.
| CHS cohort | Caucasians | African Americans | ||
|---|---|---|---|---|
| P | P | |||
| Genotype | n= 2,733 | n= 566 | ||
| rs2248690 | 1.12 (1.00– 1.26) | 0.05 | 0.98 (0.74– 1.29) | 0.87 |
| rs4917 | 1.02 (0.91– 1.14) | 0.73 | 0.88 (0.67–1.17) | 0.39 |
| Genetically predicted fetuin-A | n= 2,733 | n= 566 | ||
| rs2248690 | 0.84 (0.70– 1.00) | 0.05 | 1.06 (0.47– 2.42) | 0.89 |
| rs4917 | 0.97 (0.82– 1.14) | 0.72 | 1.34 (0.72– 2.48) | 0.36 |
| Both variants | 0.93 (0.79– 1.09) | 0.35 | 1.26 (0.70– 2.28) | 0.44 |
Association of AHSG genotypes and risk of CHD was assessed by ordinary Cox– regression and association of genetically predicted fetuin-A and risk of CHD was assessed by two-stage Cox-regression. All analyses were adjusted for age, sex, and clinic. Participants reporting previous CVD were excluded from the analyses.